Anne B Knol1
, Jeroen J de Hartog1,2
, Hanna Boogaard2
, Pauline Slottje1
, Jeroen P van der Sluijs2,3
, Erik Lebret1,2
, Flemming R Cassee1
, J Arjan Wardekker3
, Jon G Ayres4
, Paul J Borm5
, Bert Brunekreef2,6
, Kenneth Donaldson7
, Francesco Forastiere8
, Stephen T Holgate9
, Wolfgang G Kreyling10
, Benoit Nemery11
, Juha Pekkanen12
, Vicky Stone13
, H-Erich Wichmann10
and Gerard Hoek2 
1
Dutch National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
2
University of Utrecht, Institute for Risk Assessment Sciences, Utrecht, The Netherlands
3
University of Utrecht, Copernicus Institute, Utrecht, the Netherlands
4
Institute of Occupational & Environmental Medicine, University of Birmingham, Birmingham, UK
5
Centre of Expertise in Life Sciences, Hogeschool Zuyd, Heerlen, The Netherlands
6
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
7
University of Edinburgh Centre for Inflammation Research, Edinburgh, UK
8
Department of Epidemiology, Health Authority Rome, Italy
9
University of Southampton, School of Medicine, UK
10
Institute of Lung Biology and Focus Network Nanoparticles and Health, Helmholtz Center Munich, Neuherberg/Munich, Germany
11
Lung Toxicology Research Unit, K.U. Leuven, Leuven, Belgium
12
National Public Health Institute, Unit of Environmental Epidemiology, Kuopio, Finland
13
School of Life Sciences, Napier University, Edinburgh, UK